Home Strains Research Conditions Breeders Compare Explorer Blog

Command Palette

Search for a command to run...

BudProfiles

The world's most comprehensive cannabis strain directory, backed by scientific research.

11,121 strains · 12,304 studies · 268 breeders

Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Recep — 2023 Clinical Trial | BudProfiles

Home

Studies

Efficacy and Safety of Lenabasum, a Cannabinoid Ty...

InconclusiveClinical Trial2023

Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis

View Study

Classification Results

AI Classification

Inconclusive

Fine-tuned Classification

N/A

Conditions Studied

Skin Diseases Systemic Sclerosis

Related Studies

Inconclusive

Pharmacokinetics of cannabidiol, (-)-trans-Δ9-tetrahydrocannabinol, and their oxidative metabolites after intravenous and oral administration of a cannabidiol-dominant full-spectrum hemp product to beagle dogs

2025·Animal Study - Veterinary Clinical Trial

Inconclusive

PREVALENCE OF SKIN MYCOSES IN GANJA, AZERBAIJAN REPUBLIC

2025·Review/Other

N/A

Role of Cannabis in the Management of Chronic Non-Cancer Pain: A Narrative Review

2025·Review/Other

N/A

Hemp (Cannabis sativa) - An Underexploited but Promising Oilseed with Multifarious Properties and Applications: A Review

2025·Animal Study - Veterinary Clinical Trial

Positive

THERAPEUTIC EFFECT OF CANNABIDIOL (CBD) IN PLAQUE PSORIASIS

2025·Review/Other

Inconclusive

Over the counter CBD products in Germany: an exploratory survey about consumption patterns and health related effects

2025·Review/Other

Cannabinoids

Synthetic Cannabinoid (unspecified)

Organ Systems

Integumentary System

Study Details

Type: Clinical Trial
Year: 2023
Study ID: #2023019